Mystic Pharmaceuticals, Inc.

A review.Innovative delivery technologies for the needle-free delivery of vaccines by the intranasal route offer advantages to traditional parenteral needle-based delivery systems developed and produced by the vaccine industry.Dry powder intranasal vaccine technologies have recently been developed.In addition, a rapid manufacturing technol. platform is described that offers distinct advantages for delivery of liquid vaccines, with future development for a breakthrough in situ aseptic reconstitution technol. for freeze-dried or spray-dried vaccine powders.This latter advance offers the potential for eliminating or markedly reducing the need for cold-chain management of vaccines during transport and storage.These new technologies have wide-ranging applications and advantages for the reliable and effective administration of vaccine products.